Clindamycin and Gepotidacin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 1, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Clindamycin
Gepotidacin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Gepotidacin (Blujepa) can slow down a liver enzyme called CYP3A4 that helps your body break down certain other medicines. When that enzyme is slowed, some drugs can build up in your blood and cause stronger effects or more side effects.
Clindamycin is partly handled by this same enzyme. Taking the two together could raise clindamycin levels a bit. The bigger concern noted in the data is really about narrow-margin drugs, but this is still worth flagging. The good news is this is very manageable. Your pharmacist or doctor can check your medicines, adjust things if needed, and keep an eye on how you feel.
Mechanism: Gepotidacin inhibits CYP3A4, reducing metabolism of CYP3A4 substrates and increasing their exposure. Neither agent is metabolically activated in a way that reverses this direction.
- Direction: Increased substrate exposure (increases drug effect).
- Magnitude: A probe study with midazolam (supratherapeutic gepotidacin dosing) showed a 1.9-fold increase in AUC(0-inf). Clindamycin is a partial CYP3A4 substrate; expected effect is likely modest.
- Evidence: Probable. Onset: Unspecified.
- Severity on file: Major, driven chiefly by narrow-therapeutic-index CYP3A4 substrates.
Management: Avoid combining gepotidacin with NTI CYP3A4 substrates. For clindamycin, monitor for enhanced effect/adverse events; individualize therapy.
What happens
Increased CYP3A4 substrate with NTI exposure
Interaction Deep Dive
Concurrent use of gepotidacin with CYP3A4 substrates that have a narrow therapeutic index should be avoided, since exposure to the NTI CYP3A4 substrate may rise. When midazolam (a CYP3A4 substrate) was given as a single 2 mg dose alongside gepotidacin (two 3,000 mg doses administered 12 hours apart, which is not an approved gepotidacin dosage), the midazolam AUC(0 to inf) increased 1.9-fold 1.
Why it happens (mechanism)
Inhibition of CYP3A4-substrate metabolism by gepotidacin
How to manage this interaction
What your care team may do:
- Review whether these two need to overlap, or consider an alternative if a better option exists.
- Watch you a little more closely for stronger clindamycin effects or side effects while both are used.
- Adjust and individualize therapy if needed.
What you should do:
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Tell your pharmacist or doctor you are on both so they can confirm it is right for you.
- Report any new or worsening side effects, such as significant stomach upset or diarrhea.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) Coadministration of midazolam (a CYP3A4 substrate) as a single 2 mg dose together with gepotidacin (two 3,000 mg doses administered 12 hours apart, which is not an approved gepotidacin dosage) produced a 1.9-fold rise in midazolam AUC(0 to inf) 1.
Common questions
Can I take Clindamycin and Gepotidacin together?
Gepotidacin can slow the breakdown of clindamycin and raise its levels, so let your pharmacist or prescriber know you take both and report any new side effects. This is manageable with review and monitoring. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Clindamycin and Gepotidacin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Clindamycin and Gepotidacin interaction managed?
What your care team may do: Review whether these two need to overlap, or consider an alternative if a better option exists. Watch you a little more closely for stronger clindamycin effects or side effects while both are used. Adjust and individualize therapy if needed. What you should do: Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Tell your pharmacist or doc… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Clindamycin or Gepotidacin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: BLUJEPA oral tablets, gepotidacin oral tablets. GlaxoSmithKline (per FDA), Durham, NC, 2025. DailyMed
Keep reading about Clindamycin
Keep reading about Gepotidacin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist